Nutrigenomic approach to study the potential role of walnut polyphenols and their human metabolites in cancer prevention and treatment
- Autores: Claudia Alejandra Sánchez González
- Directores de la Tesis: V. Noé (dir. tes.), María Izquierdo Pulido (dir. tes.)
- Lectura: En la Universitat de Barcelona ( España ) en 2015
- Idioma: inglés
- Tribunal Calificador de la Tesis: María del Carmen López Sabater (presid.), Carlota Oleaga Sancho (secret.), Montserrat Fitó Colomer (voc.)
- Materias:
- Enlaces
- Tesis en acceso abierto en: TDX Dipòsit Digital de la UB
- Resumen
Epidemiologic studies and clinical trials have demonstrated consistent benefits of walnut (Juglans regia L.) consumption. Walnuts have been described as a rich source of polyphenols with a broad array of different structures. However, an accurate screening of its complete phenolic profile was lacking. Using liquid chromatography coupled with electrospray ionization hybrid linear trap quadrupole-Orbitrap mass spectrometry (LC–LTQ-Orbitrap) a comprehensive identification of phenolic compounds in walnuts was performed. A total of 120 compounds were identified, with ellagitannins, ellagic acid and its derivatives, as major polyphenols in walnuts. After consumption, ellagitannins are hydrolyzed to release ellagic acid, which is converted by gut microflora to urolithin A (UA) and urolithin B (UB). Ellagitannins and their metabolites have been shown to slow down cancer development and progression. The identification of dietary agents that may modulate molecular pathways related to cancer is of great interest. Therefore, the main aim of this study was to determine gene expression changes induced by urolithins using a nutrigenomic approach. We investigated the effects of urolithins on the expression of prostate specific antigen and the androgen receptor in a prostate cancer cell model. The mRNA and protein levels of both prostate specific antigen and androgen receptor were down-regulated after incubating LNCaP cells with urolithins A and B. Transient transfection of PC-3 cells with a luciferase construct driven by the PSA-promoter containing three androgen response elements showed that urolithins inhibited AR-mediated PSA expression at the transcriptional level. Electrophoretic Mobility Shift Assays revealed that urolithins decreased the androgen receptor binding to its consensus Response Element. In addition, we performed a genomic analysis to study the effect of UA on whole genome expression in LNCaP cells. CDKN1A, a node gene determined by Biological Association Networks (BANs) using the list of differentially expressed genes, was further validated; its promoter activity, mRNA and protein levels were significantly up-regulated. The role urolithins have in the modulation of the cell cycle and apoptosis induction was also explored. Cell cycle was measured by flow cytometry, and apoptosis was determined by caspase 3/7 activation and using the rhodamine method. Cell cycle analyses showed an increase at G1, we also observed an induction of apoptosis and caspase 3/7 activation and this effect correlated with a decrease in the anti-apoptotic protein Bcl-2. Our results suggest that urolithins A and B attenuate the function of the AR by repressing its expression. A down-regulation of AR and PSA mRNA and protein levels could provoke an interruption of the interaction between PSA and AR, with a proven role in prostate cancer development and progression. In addition a clear effect of urolithin A on whole genome expression in a prostate cancer cell model was observed. The significant up regulation of p21, which has a known role in cell cycle and apoptosis, correlated with an increased percentage of cells in the G1 phase of the cell cycle, furthermore, the multi-targeted effects of urolithins resulted in an induction of apoptosis. The aforementioned results indicate a potential role of walnuts as a chemo-preventive and/or chemo-therapeutic agent for prostate cancer.
